久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Newsmakers

Hoarding blamed for gulf in access to jabs

By AI HEPING in New York | China Daily | Updated: 2021-04-30 07:37
Share
Share - WeChat
Members of security forces stand guard next to refrigerated containers with doses of Pfizer-BioNTech vaccines against the coronavirus disease (COVID-19) after they were unloaded from an airplane at Viracopos International Airport, in Campinas, Brazil, April 29, 2021. [Photo/Agencies]

Stockpiles in rich nations, along with patent protection, mean most miss out

Developing countries are struggling with a shortage of coronavirus vaccines, with the hoarding of supplies and the protection of intellectual property in affluent nations two reasons why.

The causes vary globally, but the major factors are the national hoarding of doses, raw materials and technical expertise; patents and liability protection by pharmaceutical companies that prevent countries from sharing vaccines; and the locking up of vaccine production by the world's wealthiest countries.

Drug companies that developed and won authorization for the vaccines in record time have agreed to sell most of the first doses off production lines to the United States, European countries and a few other wealthy nations.

Tedros Adhanom Ghebreyesus, the director-general of the World Health Organization, has described the situation as "another brick in the wall of inequality between the world's haves and have-nots".

"It's outrageous ethically, morally, scientifically," Maria Van Kerkhove, a public health researcher with the WHO, told The Washington Post about the global vaccine inequities.

The health agency will soon decide whether to give emergency approval for China's two main COVID-19 vaccines, WHO Assistant Director-General Mariangela Batista Galvao Simao said on Monday.

If the WHO grants emergency use authorization for the two Chinese vaccines, it will be a boost for the COVID-19 Vaccines Global Access, or COVAX, program and give the green light to some developed countries anxiously awaiting the endorsement so they can import the Chinese vaccines.

WHO approval should be a formality as the Chinese vaccines' safety and efficacy have been tested and proven. More than 200 million Chinese vaccine doses have been administered domestically and 100 million in foreign countries, particularly in Latin America, Asia and Africa.

'Vaccine nationalism'

So-called vaccine nationalism also is said to be hindering the flow of doses to poorer nations through COVAX. The program is jointly run by Gavi, the Vaccine Alliance, the WHO and the Coalition for Epidemic Preparedness Innovations and is an effort to pool resources to develop and equitably distribute vaccines to 92 low-and middle-income countries this year.

India, which is the world's largest vaccine producer-mostly producing the AstraZeneca formula-has sold and gifted tens of millions of doses to other countries as part of COVAX. But it has largely stopped exporting due to its own surge in cases.

COVAX had expected 71 percent of its initial doses to come from India's Serum Institute, the country's largest vaccine maker, dealing a major setback to the rollout.

The gulf in vaccine access has spurred calls to waive intellectual property protections.

Columbia University Professor Joseph Stiglitz, along with Lori Wallach, the director of Public Citizen's Global Trade Watch, argued in an opinion article in The Washington Post on Monday that "preserving intellectual property barriers to COVID-19 vaccines is morally wrong and foolish".

They wrote that "waiving intellectual property rights so developing countries could produce more vaccines would make a big difference in reaching global herd immunity".

Three-quarters of the world's vaccine doses have been administered in just 10 nations, which together account for under half the world's population.

"At the current rate vaccines are being administered, 92 of the world's poorest countries won't vaccinate 60 percent of their populations until 2023 or later," wrote Krishna Udayakumar and Mark McClellan, health experts at Duke University.

The low rate of vaccination globally makes it harder to reach herd immunity, in which a sufficient percentage of the population is inoculated, making it much more difficult for the virus to mutate. But if the mutations prove resistant to vaccines, they could spread anywhere in the world, including in Western countries that have been vaccinated first.

India, where barely 1 percent of the population has been vaccinated, is battling the world's fastest pace of spreading coronavirus infections.

With 379,257 new infections, India now has reported more than 18.3 million cases, second only to the United States. The Health Ministry also reported 3,645 deaths in the last 24 hours, bringing the total to 204,832.

Agencies contributed to this story.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 2021国产精品自在拍在线播放 | 99视频免费 | 亚久久伊人精品青青草原2020 | 国产精品福利午夜一级毛片 | 日韩一级免费毛片 | 亚洲第一区视频 | 日韩欧美在线观看 | 欧美精品首页 | 久久青草免费免费91线频观看 | 天码毛片一区二区三区入口 | 国产精品亚洲专一区二区三区 | 五月色婷婷琪琪综合伊人 | 中文字幕在线免费观看视频 | 成人在线播放 | 亚洲依依成人综合在线网址 | 国产成人亚洲合集青青草原精品 | 婷婷亚洲久悠悠色在线播放 | 国产精品亚洲一区二区三区 | 成年男人午夜片免费观看 | 成人免费网站视频 | 亚洲成人综合视频 | 亚洲国产日韩女人aaaaaa毛片在线 | 亚洲成av人影片在线观看 | 国产一级片观看 | 精品丝袜国产自在线拍亚洲 | 一区不卡在线观看 | 国产中文字幕视频在线观看 | 免费看v片网站 | 亚洲国产成人精彩精品 | 精品国产高清不卡毛片 | 日韩免费一级a毛片在线播放一级 | a级成人毛片免费视频高清 a级高清观看视频在线看 | 天堂视频在线免费观看 | 亚洲视频在线免费播放 | 自拍偷拍亚洲区 | 国产精品亚洲片在线不卡 | 久草欧美 | 国产人成久久久精品 | 亚洲国产99在线精品一区二区 | 一级视频在线免费观看 | 精品在线看 |